Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mucosal Lentiginous Melanoma × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1481 Skin Neoplasms 319 Lymphoma, T-Cell, Cutaneous 294 Carcinoma, Basal Cell 210 Mycosis Fungoides 206 Sezary Syndrome 189 Lymphoma, Non-Hodgkin 175 Leukemia, Lymphocytic, Chronic, B-Cell 173 Breast Neoplasms 173 Lymphoma, Follicular 167 Precursor Cell Lymphoblastic Leukemia-Lymphoma 165 Lymphoma, Large B-Cell, Diffuse 164 Lymphoma, Mantle-Cell 162 Lymphoma, B-Cell, Marginal Zone 162 Lymphoma 159 Burkitt Lymphoma 156 Hodgkin Disease 155 Lymphoma, Large-Cell, Immunoblastic 154 Uveal Melanoma 149 Multiple Myeloma 144 Keratosis, Actinic 135 Neoplasms 124 Leukemia, Myeloid, Acute 120 Neoplasm Metastasis 110 Lymphoma, Large-Cell, Anaplastic 110 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 109 Lung Neoplasms 105 Immunoblastic Lymphadenopathy 103 Leukemia, Myeloid, Accelerated Phase 101 Leukemia, Myeloid, Chronic-Phase 100

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01395121 2017-06-08

NICAM

Institute of Cancer Research, United Kingdom

Phase 2 Completed

Mucosal Lentiginous Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡